120 related articles for article (PubMed ID: 8042044)
1. Surgical adjuvant treatment of esophageal carcinoma: a Japanese Esophageal Oncology Group experience.
Iizuka T
Semin Oncol; 1994 Aug; 21(4):462-6. PubMed ID: 8042044
[TBL] [Abstract][Full Text] [Related]
2. [Problems and present status of clinical trials for esophageal carcinoma].
Hayashi K; Ide H
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():348-55. PubMed ID: 7986114
[TBL] [Abstract][Full Text] [Related]
3. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
4. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
[TBL] [Abstract][Full Text] [Related]
5. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
8. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
9. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
Fréchette E; Buck DA; Kaplan BJ; Chung TD; Shaw JE; Kachnic LA; Neifeld JP
J Surg Oncol; 2004 Aug; 87(2):68-74. PubMed ID: 15282698
[TBL] [Abstract][Full Text] [Related]
10. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.
Ando N; Iizuka T; Ide H; Ishida K; Shinoda M; Nishimaki T; Takiyama W; Watanabe H; Isono K; Aoyama N; Makuuchi H; Tanaka O; Yamana H; Ikeuchi S; Kabuto T; Nagai K; Shimada Y; Kinjo Y; Fukuda H;
J Clin Oncol; 2003 Dec; 21(24):4592-6. PubMed ID: 14673047
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
13. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
Msika S; Hay JM
J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
15. [Esophageal cancer: did combined treatments improve prognosis?].
Ganem G; Raoul Y; Goudier MJ; Dubray B; Colin P; Extra JM; Hennequin C; Michel-Langlet P; Vignoud J; Bardet E
Bull Cancer; 1992; 79(8):735-50. PubMed ID: 1467597
[TBL] [Abstract][Full Text] [Related]
16. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
An FS; Huang JQ; Xie YT; Chen SH; Rong TH
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571
[TBL] [Abstract][Full Text] [Related]
17. [Radio- and chemotherapy of cancer of the esophagus].
Tiret E
Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
19. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
